Literature DB >> 32333891

Refining endpoints for stroke recovery trials.

Dirk M Hermann1, Claudio L Bassetti2, Ute Marx3, Marie-Laure Audoli-Inthavong3, Hugues Chabriat4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32333891     DOI： 10.1016/S1474-4422(20)30101-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  Hot Topics in Cellular Neuropathology II: Promoting Neuronal Plasticity in the Injured Central Nervous System.

Authors:  Dirk M Hermann
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

2.  Association of Modified Rankin Scale With Recovery Phenotypes in Patients With Upper Extremity Weakness After Stroke.

Authors:  Kimberly S Erler; Rui Wu; Julie A DiCarlo; Marina F Petrilli; Perman Gochyyev; Leigh R Hochberg; Steven A Kautz; Lee H Schwamm; Steven C Cramer; Seth P Finklestein; David J Lin
Journal:  Neurology       Date:  2022-03-11       Impact factor: 11.800

3.  The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity.

Authors:  Ferenc A Antoni
Journal:  Life (Basel)       Date:  2022-02-21

Review 4.  The Utility of Domain-Specific End Points in Acute Stroke Trials.

Authors:  Steven C Cramer; Steven L Wolf; Jeffrey L Saver; Karen C Johnston; J Mocco; Maarten G Lansberg; Sean I Savitz; David S Liebeskind; Wade Smith; Max Wintermark; Jordan J Elm; Pooja Khatri; Joseph P Broderick; Scott Janis
Journal:  Stroke       Date:  2021-02-10       Impact factor: 7.914
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.